Tech entrepreneur and “biohacker” Bryan Johnson, 48, says he has “cloned himself as a baby” as part of an effort to explore new medical therapies. Across reports, Johnson presents his work as a way to advance research aimed at reversing aging and treating disease, including by enabling tests of therapies and potential tissue repair. One outlet describes his claim in more specific terms: he says adult cells can be reprogrammed in a laboratory into a stem cell-like state, which he frames as an approach to create an embryo-like biological system for research purposes. Another account says Johnson links the concept to plans for organ harvesting, describing it as a “frontier of new paths” to reverse aging. The reporting also notes that Johnson describes his condition as incurable, and that his announcement has prompted debate about the future of medicine and the ethics of cloning and organ-related research. The articles do not provide independent verification or detailed evidence of the cloning claim, but they consistently report Johnson’s statements and the controversy surrounding them.